Centrus Energy (LEU) Lands New HALEU Deal with Antares

Centrus Energy Corp. (NYSE:LEU) reported on September 17 that it had signed a multi-year contract to supply high-assay low-enriched uranium (HALEU) to Antares Nuclear, with deliveries expected to begin before the end of the decade. Although financial terms were not disclosed, the deal includes prepayments from Antares to help fund Centrus' expanded HALEU capacity.

The deal holds strategic importance as Antares is developing compact microreactors for critical missions on Earth and in space. The company was also recently selected for the U.S. Army's Janus Program, a $2.2 billion initiative to build and operate tiny nuclear reactors on military bases, with the hope that they will one day power remote installations.

Amir Vexler, President and CEO of Centrus Energy, commented:

"This contract is another sign that demand for HALEU is real and it is accelerating, and Centrus is in prime position to meet this need. Binding orders from Antares and others are supporting our expansion to commercial-scale production – an expansion that is now well underway. We look forward to supporting Antares' continued growth and success."

dan-meyers-xXbQIrWH2_A-unsplash

Antares Deal Adds Fuel to Centrus' Growth:

The Antares deal provides additional evidence that HALEU demand is moving from a development concept toward contracted commercial demand. Centrus is well-positioned to capitalize on the opportunity, as its enrichment technology is already transitioning from demonstration to commercial-scale production.

The company is pioneering HALEU production at its enrichment facility in Ohio, the only licensed HALEU production facility in the Western world. Last year, the company launched a multi-billion-dollar expansion to increase production of HALEU and conventional low-enriched uranium. As the Antares agreement includes prepayments, it will help reduce some of the financial burden associated with scaling production.

The latest contract adds to Centrus Energy's backlog of $4.5 billion as of the end of the second quarter, including about $3 billion of contingent LEU and HALEU sales commitments. Notably, around $2.4 billion of these commitments are under definitive agreements, increasing confidence that portions of the backlog can eventually translate into material revenue.

The Deal Lacks Near-Term Impact:

The financial contributions from the Antares deal remain hard to quantify, since the companies did not disclose the contract value, pricing, or specific delivery volumes. Moreover, deliveries are not scheduled to commence until before the end of the decade, meaning that the agreement does not provide any immediate boost to revenue or earnings.